secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuronetics, Inc. (STIM)
CIK:        0001227636
Form:       8-K
Filed at:   2026-08-11T12:05:08+00:00
Accession:  0001193125-26-343474
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neuronetics Q2 revenue up 9.1% to $41.6M; EBITDA turns positive at $0.3M
------------------------------------------------------------------------

- Q2 total revenue $41.6M, +9.1% YoY; Greenbrook $26.9M +16.8%, NeuroStar $14.7M -2.7%.
- Net loss narrowed to $3.4M ($0.05/sh) from $10.1M; adjusted EBITDA $0.3M vs -$5.6M.
- Gross margin up to 51.1% from 46.6%; operating expenses down 12% to $22.7M.
- FY2026 guidance: revenue narrowed to $160-164M; gross margin raised to 48-50%; opex cut to $95-100M.
- Nir Naor named EVP/CFO; Cory Anderson promoted EVP/GM Greenbrook; Rob Greene SVP Sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1227636/000119312526343474/0001193125-26-343474-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1227636/000119312526343474/d78613d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-343474

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer